A NEW dataset of Matched Physicians & Patients in Narcolepsy
As the treatment landscape for narcolepsy continues to evolve, understanding the current treatment paradigm in real-world settings remains critically important. With promising therapies in development which may have disease-modifying potential, it is essential to evaluate how existing treatments are performing in practice, the real-world burden of disease, and what emerging options may mean for the future of narcolepsy management.
Obtaining high-quality real-world evidence is essential to support clinical strategies, inform healthcare decision-making, and demonstrate clinical and quality-of-life value to key stakeholders.
Adelphi Real World’s Disease Specific Programmes (DSPs) are purpose-built to address these challenges.
Our Narcolepsy DSP provide comprehensive, real-world insights into treatment decision making and patient experiences. By engaging directly with neurologists, psychiatrists, pulmonologists, primary care physicians and patients, our DSP deliver granular perspectives on:
Treatment Sequencing & Management Patterns
Understand real-world therapy selection, combination strategies, and sequential treatment approaches for patients with type 1 and type 2 narcolepsy.
Physician Decision-Making
Explore the physician reasoning behind treatment choices, factors influencing therapy selection in narcolepsy management.
Patient Experience & Outcomes
Gain insights into real-world adherence, satisfaction with treatment, and patient-reported lived experiences, including impact of narcolepsy on work, lifestyle and quality of life.
Emerging Unmet Needs
Uncover treatment challenges, gaps in narcolepsy management, emerging therapeutic opportunities and treatment access barriers. Explore opportunities for therapeutic advancement to better support patients with narcolepsy.
Narcolepsy Disease Specific Programmes (DSP)
Idiopathic Hypersonmia Disease Specific Programme (DSP)
We are currently in the planning stages for a new DSP in Idiopathic Hypersonmia, with opportunities for early subscriber input into questionnaire content.
Why Partner With Adelphi Real World for Sleep Disorder Research?
Extensive Global Coverage
Our DSP network spans multiple countries, providing robust comparative insights into sleep medicine practice, treatment adoption, diagnostic approaches, and healthcare delivery across diverse healthcare systems.
Deep Clinical Expertise
With specialised knowledge of sleep disorders, we ensure our data collection, analysis, and interpretation reflect the true complexity of sleep disease management and the needs of treating clinicians and patients.
Evidence That Drives Impact
From clinical development to reimbursement and healthcare provider engagement, our DSPs provide the credible, compelling evidence needed to influence decisions across the healthcare ecosystem.
Let’s Get Started
-
Schedule a Consultation: Meet with our team to discuss how our DSPs can support your research, development, and market access objectives across neurological sleep disorders.
-
Get More Details: Want to explore our methodology, global reach, patient insights, or specialist networks? We’re here to answer your questions and provide customised information.
Adelphi Real World brings together real-world expertise, disease insight, and global reach to help you succeed in sleep disorder research. Let’s collaborate to advance evidence and improve outcomes for patients with sleep disorders.
Contact us today using the form below.
Conferences Attending
Observational Research